These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23873259)

  • 61. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
    Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
    J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.
    Ramos-Lima FJ; Moneo V; Quiroga AG; Carnero A; Navarro-Ranninger C
    Eur J Med Chem; 2010 Jan; 45(1):134-41. PubMed ID: 19853978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl) ethylenediamine]dichloroplatinum(II)-complexes, Part II: Biological properties.
    Jennerwein M; Gust R; Müller R; Schönenberger H; Engel J; Berger MR; Schmähl D; Seeber S; Osieka R; Atassi G
    Arch Pharm (Weinheim); 1989 Feb; 322(2):67-73. PubMed ID: 2730292
    [TBL] [Abstract][Full Text] [Related]  

  • 65. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased targeting of adenine-rich sequences by (2-amino-2-methyl-3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicity.
    Hambley TW; Ling EC; O'Mara S; McKeage MJ; Russell PJ
    J Biol Inorg Chem; 2000 Dec; 5(6):675-81. PubMed ID: 11128994
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.
    Sun Y; Gou S; Yin R; Jiang P
    Eur J Med Chem; 2011 Oct; 46(10):5146-53. PubMed ID: 21875765
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA interaction of a fluorescent, cytotoxic pyridinimino platinum(II) complex.
    Bondi R; Biver T; Dalla Via L; Guarra F; Hyeraci M; Sissi C; Labella L; Marchetti F; Samaritani S
    J Inorg Biochem; 2020 Jan; 202():110874. PubMed ID: 31683086
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
    Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)(DMSO or Picolino)Cl complexes.
    Rahman FU; Ali A; Guo R; Zhang YC; Wang H; Li ZT; Zhang DW
    Dalton Trans; 2015 Feb; 44(5):2166-75. PubMed ID: 25510629
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis, activity and binding with DNA of [{trans-PtCl(NH(3))(2)}(2)micro-{trans-Pd(4-hydroxypyridine) (2) (H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (TH8).
    Huq F; Tayyem H; Yu JQ; Beale P; Fisher K
    Med Chem; 2009 Jul; 5(4):372-81. PubMed ID: 19689395
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
    Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
    Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
    Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
    Saris CP; van de Vaart PJ; Rietbroek RC; Blommaert FA
    Carcinogenesis; 1996 Dec; 17(12):2763-9. PubMed ID: 9006117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.